| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |